Virtual 4D Treatment Suite for Radiation Dose Temporal Variation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiation therapy techniques face challenges in managing the motion of tumors and critical structures during treatment, leading to temporal variations in radiation dose delivery, especially due to breathing-induced motion, which can result in inconsistent treatment outcomes.
Innovation Solution
A virtual four-dimensional (4D) treatment suite is developed, incorporating a dose calculation module, a gating module, and a dose rate adjustment module to predict and manage the effects of tumor motion, allowing for the evaluation of proposed treatment plans and the application of dose management techniques such as gating and dose rate adjustments to minimize temporal dose variation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If radiation therapy is delivered to treat target tissue, then malignant cells are controlled, but temporal variations in radiation dose occur due to tumor motion
Solution Approach 1:
The system performs preliminary simulation of tumor motion and its effect on dose delivery before actual treatment. The motion simulation module predicts tumor position variations, and the dose calculation module pre-calculates how these motions will affect dose distribution, allowing clinicians to plan compensatory measures in advance
Solution Approach 2:
The system creates a virtual copy of the treatment process through simulation. A motion simulation model replicates tumor motion patterns, and a virtual dose calculation system models dose delivery under various motion conditions, allowing evaluation of treatment robustness without exposing the patient to actual radiation
2Object-affected harmful factors
If MLC leaves are adjusted to shape beam to conform to treatment field, then critical structures are avoided, but temporal variation in dose increases due to tumor motion during delivery
Solution Approach 1:
The system pre-simulates the interaction between MLC leaf positions and tumor motion trajectories. Before treatment delivery, the motion simulation module generates expected tumor positions, and the dose calculation module evaluates how MLC configurations will perform across these positions, allowing optimization of leaf sequences to maintain both coverage and avoidance
Solution Approach 2:
The system models the dynamic interaction between movable MLC leaves and moving tumor throughout treatment delivery. The simulation tracks time-varying positions of both MLC leaves and tumor, evaluating dose accumulation patterns that result from the coordinated motion of beam shaping elements and target
3Quantity of substance
If treatment beam is delivered to encompass target tissue, then tumor receives sufficient dose, but normal tissue surrounding target receives excessive radiation
Solution Approach 1:
The system performs preliminary evaluation of dose distributions under various tumor motion scenarios. The dose calculation module computes dose to both target and normal tissues accounting for motion-induced position variations, allowing clinicians to identify plans that maintain adequate target coverage while limiting normal tissue exposure
Solution Approach 2:
The system evaluates and optimizes dose distribution locally across different spatial regions. The dose calculation module computes dose metrics separately for target tissue volumes and surrounding normal structures, enabling assessment of whether motion causes unacceptable dose escalation to specific normal tissue regions while maintaining target coverage
Data Source
AI summary
A virtual 4D treatment suite includes a dose calculation module, a gating module, and a dose rate adjustment module. The 4D treatment suite may be used to virtually analyze the impact the motion of a target tissue has on therapy for a particular patient and a proposed treatment plan. For example, for a proposed treatment plan, the dose calculation module may calculate a dose that would be received by a target tissue and an associated dose temporal variation based on an identified movement of the target tissue relative to at least a portion of a treatment field. Based on the calculated expected therapy dose and dose temporal variation, the gating module may determine whether to implement a gating technique for the proposed treatment plan and/or the dose rate adjustment module may determine whether to adjust the dose rate of the proposed treatment plan.